Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018
07 Jan, 2026 | 04:47pm • Source: BSE
Resignation of Senior Management Personnel
27 Dec, 2025 | 04:36pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ruby Qc Investment Holdings Pte...
22 Dec, 2025 | 03:40pm • Source: BSE
Plant Visit of Investors / Financial Institutions on 12.12.2025
09 Dec, 2025 | 03:08pm • Source: BSE
JM Financial India Conference 2025
17 Nov, 2025 | 01:23pm • Source: BSE
Earning call transcript
17 Nov, 2025 | 01:19pm • Source: BSE
Intimation of Schedule of the Analysts/Investor Meet (Group Meet)
14 Nov, 2025 | 04:23pm • Source: BSE
Intimation of Schedule of the Analysts/Investor Meet (Group Meet)
14 Nov, 2025 | 04:23pm • Source: BSE
Intimation of Schedule of the Analysts/Investor Meet (Group Meet)
14 Nov, 2025 | 04:23pm • Source: BSE
Intimation of Schedule of the Analysts/Investor Meet (Group Meet)
14 Nov, 2025 | 04:23pm • Source: BSE
Intimation of Schedule of the Analysts/Investor Meet (Group Meet)
14 Nov, 2025 | 04:23pm • Source: BSE
Audio Recording
14 Nov, 2025 | 02:47pm • Source: BSE
Newspaper Publication
14 Nov, 2025 | 02:33pm • Source: BSE
Intimation of Schedule of the Earnings / Analysts Conference Call
10 Nov, 2025 | 05:08pm • Source: BSE
Incorporation of Wholly Owned Subsidiary in Malta
20 Oct, 2025 | 01:31pm • Source: BSE
Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
14 Oct, 2025 | 02:24pm • Source: NSE